These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9806055)

  • 1. The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California.
    Kemper CA; Gangar M; Arias G; Kane C; Deresinski SC
    J Infect Dis; 1998 Oct; 178(4):1177-80. PubMed ID: 9806055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
    BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity.
    Kemper CA; Zolopa AR; Hamilton JR; Fenstersheib M; Bhatia G; Deresinski SC
    AIDS; 1992 Nov; 6(11):1321-5. PubMed ID: 1472336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring HIV infection and susceptibility to measles among older children and adults in Malawi: a facility-based study.
    Polonsky JA; Singh B; Masiku C; Langendorf C; Kagoli M; Hurtado N; Berthelot M; Heinzelmann A; Puren A; Grais RF
    Int J Infect Dis; 2015 Feb; 31():61-7. PubMed ID: 25499042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults.
    Sha BE; Harris AA; Benson CA; Atkinson WL; Urbanski PA; Stewart JA; Williams WW; Murphy RL; Phair JP; Levin SA
    J Infect Dis; 1991 Nov; 164(5):973-5. PubMed ID: 1682395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles seroprevalence and vaccine response in HIV-infected adults.
    Wallace MR; Hooper DG; Graves SJ; Malone JL
    Vaccine; 1994 Oct; 12(13):1222-4. PubMed ID: 7839728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.
    Lambert D; Dramé M; Rouger C; Brodard V; Nguyen Y; Berger JL; Kmiec I; Hentzien M; Lebrun D; Jaussaud R; Andreoletti L; Bani-Sadr F
    AIDS; 2015 Jan; 29(2):241-3. PubMed ID: 25486416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples.
    Scott S; Cumberland P; Shulman CE; Cousens S; Cohen BJ; Brown DW; Bulmer JN; Dorman EK; Kawuondo K; Marsh K; Cutts F
    J Infect Dis; 2005 Jun; 191(11):1854-60. PubMed ID: 15871118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    Dauby N; Martin C; Hainaut M; Grammens T; Van den Wijngaert S; Delforge M; De Wit S
    HIV Med; 2018 Jul; 19(6):426-429. PubMed ID: 29573535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.
    Zolopa AR; Kemper CA; Shiboski S; Hamilton JR; Moss AR; Deresinski SC
    Clin Infect Dis; 1994 Apr; 18(4):636-8. PubMed ID: 8038324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
    Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
    J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    Lefebvre M; Secher S; Bouchez S; Vandamme YM; Fialaire P; Leautez S; Blanchi S; Michau C; Coste-Burel M; Brunet-Cartier C; Reliquet V; Gregoire A; Raffi F; Allavena C;
    AIDS; 2022 Jul; 36(9):1273-1278. PubMed ID: 35262533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
    Belaunzarán-Zamudio PF; García-León ML; Wong-Chew RM; Villasís-Keever A; Cuellar-Rodríguez J; Mosqueda-Gómez JL; Muñoz-Trejo T; Escobedo K; Santos JI; Ruiz-Palacios GM; Sierra-Madero JG
    Vaccine; 2009 Nov; 27(50):7059-64. PubMed ID: 19799846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.
    Siberry GK; Patel K; Bellini WJ; Karalius B; Purswani MU; Burchett SK; Meyer WA; Sowers SB; Ellis A; Van Dyke RB; ;
    Clin Infect Dis; 2015 Sep; 61(6):988-95. PubMed ID: 26060291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants.
    Scott S; Moss WJ; Cousens S; Beeler JA; Audet SA; Mugala N; Quinn TC; Griffin DE; Cutts FT
    Clin Infect Dis; 2007 Dec; 45(11):1417-24. PubMed ID: 17990222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of measles antibody in the US population, 1999-2004.
    McQuillan GM; Kruszon-Moran D; Hyde TB; Forghani B; Bellini W; Dayan GH
    J Infect Dis; 2007 Nov; 196(10):1459-64. PubMed ID: 18008224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
    J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
    Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.